115 related articles for article (PubMed ID: 37751246)
21. ADAM12 expression predicts clinical outcome in estrogen receptor-positive breast cancer.
Ma B; Ma Q; Jin C; Wang X; Zhang G; Zhang H; Seeger H; Mueck AO
Int J Clin Exp Pathol; 2015; 8(10):13279-83. PubMed ID: 26722530
[TBL] [Abstract][Full Text] [Related]
22. Germline polymorphisms in genes involved in the Hippo pathway as recurrence biomarkers in stages II/III colon cancer.
Sebio A; Matsusaka S; Zhang W; Yang D; Ning Y; Stremitzer S; Stintzing S; Sunakawa Y; Yamauchi S; Fujimoto Y; Ueno M; Lenz HJ
Pharmacogenomics J; 2016 Aug; 16(4):312-9. PubMed ID: 26370619
[TBL] [Abstract][Full Text] [Related]
23. Bioinformatic Analyses and Experimental Verification Reveal that High FSTL3 Expression Promotes EMT
Liu Y; Li J; Zeng S; Zhang Y; Zhang Y; Jin Z; Liu S; Zou X
Front Mol Biosci; 2021; 8():762924. PubMed ID: 34901156
[No Abstract] [Full Text] [Related]
24. ERCC1, PARP-1, and AQP1 as predictive biomarkers in colon cancer patients receiving adjuvant chemotherapy.
Abdelrahman AE; Ibrahim DA; El-Azony A; Alnagar AA; Ibrahim A
Cancer Biomark; 2020; 27(2):251-264. PubMed ID: 31903985
[TBL] [Abstract][Full Text] [Related]
25. Increased expression of FAT4 suppress metastasis of lung adenocarcinoma through regulating MAPK pathway and associated with immune cells infiltration.
Ning Y; Yang Y; Zheng H; Zhan Y; Zang H; Wen Q; Peng J; Fan S
Cancer Med; 2023 Jan; 12(2):1616-1629. PubMed ID: 35770846
[TBL] [Abstract][Full Text] [Related]
26. Roles of follistatin-like protein 3 in human non-tumor pathophysiologies and cancers.
Tian S; Xu X; Yang X; Fan L; Jiao Y; Zheng M; Zhang S
Front Cell Dev Biol; 2022; 10():953551. PubMed ID: 36325361
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic inactivation of FAT4 contributes to gastric field cancerization.
Yoshida S; Yamashita S; Niwa T; Mori A; Ito S; Ichinose M; Ushijima T
Gastric Cancer; 2017 Jan; 20(1):136-145. PubMed ID: 26792292
[TBL] [Abstract][Full Text] [Related]
28. Prognostic impact of primary tumor location in Stage III colorectal cancer-right-sided colon versus left-sided colon versus rectum: a nationwide multicenter retrospective study.
Shida D; Inoue M; Tanabe T; Moritani K; Tsukamoto S; Yamauchi S; Sugihara K; Kanemitsu Y
J Gastroenterol; 2020 Oct; 55(10):958-968. PubMed ID: 32651860
[TBL] [Abstract][Full Text] [Related]
29.
Liu YJ; Li JP; Zhang Y; Nie MJ; Zhang YH; Liu SL; Zou X
Onco Targets Ther; 2021; 14():4099-4117. PubMed ID: 34262295
[TBL] [Abstract][Full Text] [Related]
30. Expression of
Chung MW; Park YL; Park SY; Joo YE
In Vivo; 2022; 36(5):2194-2204. PubMed ID: 36099146
[TBL] [Abstract][Full Text] [Related]
31. Colon Adenocarcinoma Stage IIA-Can We Predict Relapse?
Pinto JC; Rosa I; Martins C; Marques I; da Silva JP; Fonseca R; Freire J; Pereira AD
J Gastrointest Cancer; 2020 Mar; 51(1):116-120. PubMed ID: 30834501
[TBL] [Abstract][Full Text] [Related]
32. Interaction Between Macrophage Extracellular Traps and Colon Cancer Cells Promotes Colon Cancer Invasion and Correlates With Unfavorable Prognosis.
Chen T; Wang Y; Nan Z; Wu J; Li A; Zhang T; Qu X; Li C
Front Immunol; 2021; 12():779325. PubMed ID: 34925357
[TBL] [Abstract][Full Text] [Related]
33. MiR-638 inhibits cervical cancer metastasis through Wnt/β-catenin signaling pathway and correlates with prognosis of cervical cancer patients.
Wei H; Zhang JJ; Tang QL
Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5587-5593. PubMed ID: 29271990
[TBL] [Abstract][Full Text] [Related]
34. Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value.
Marisa L; de Reyniès A; Duval A; Selves J; Gaub MP; Vescovo L; Etienne-Grimaldi MC; Schiappa R; Guenot D; Ayadi M; Kirzin S; Chazal M; Fléjou JF; Benchimol D; Berger A; Lagarde A; Pencreach E; Piard F; Elias D; Parc Y; Olschwang S; Milano G; Laurent-Puig P; Boige V
PLoS Med; 2013; 10(5):e1001453. PubMed ID: 23700391
[TBL] [Abstract][Full Text] [Related]
35. FAT4 activation inhibits epithelial-mesenchymal transition (EMT) by promoting autophagy in H2228/Cer cells.
Yang Y; Li Y; Yang Q; Liu Z; Chang X; Yang H; Liu J; Li Z; Zuo D
Med Oncol; 2022 Dec; 40(1):64. PubMed ID: 36576661
[TBL] [Abstract][Full Text] [Related]
36. miR-107 regulates growth and metastasis of gastric cancer cells via activation of the PI3K-AKT signaling pathway by down-regulating FAT4.
Wang L; Li K; Wang C; Shi X; Yang H
Cancer Med; 2019 Sep; 8(11):5264-5273. PubMed ID: 31297980
[TBL] [Abstract][Full Text] [Related]
37. FAT4 regulates the EMT and autophagy in colorectal cancer cells in part via the PI3K-AKT signaling axis.
Wei R; Xiao Y; Song Y; Yuan H; Luo J; Xu W
J Exp Clin Cancer Res; 2019 Mar; 38(1):112. PubMed ID: 30832706
[TBL] [Abstract][Full Text] [Related]
38. Evaluation on prognostic efficacy of lymph nodes ratio (LNR) and log odds of positive lymph nodes (LODDS) in complicated colon cancer: the first study in emergency surgery.
Occhionorelli S; Andreotti D; Vallese P; Morganti L; Lacavalla D; Forini E; Pascale G
World J Surg Oncol; 2018 Sep; 16(1):186. PubMed ID: 30213260
[TBL] [Abstract][Full Text] [Related]
39. The novel FAT4 activator jujuboside A suppresses NSCLC tumorigenesis by activating HIPPO signaling and inhibiting YAP nuclear translocation.
Wang W; Huang Q; Chen Y; Huang Z; Huang Y; Wang Y; Qi X; Liu Z; Lu L
Pharmacol Res; 2021 Aug; 170():105723. PubMed ID: 34116210
[TBL] [Abstract][Full Text] [Related]
40. Systemic analysis of the expression levels and prognosis of breast cancer-related cadherins.
Xu M; Liu C; Pu L; Lai J; Li J; Ning Q; Liu X; Deng S
Exp Biol Med (Maywood); 2021 Aug; 246(15):1706-1720. PubMed ID: 33899544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
